Individualization of treatment with gentamicin in neonates based on drug concentration in the blood serum

1Touw DJ, Westerman EM, Sprij AJ. Therapeutic drug monitoring of aminoglycosides in neonates. Clin Pharmacokinet. 2009;48:71-88. Touw DJ Westerman EM Sprij AJ Therapeutic drug monitoring of aminoglycosides in neonates Clin Pharmacokinet 20094871 8810.2165/00003088-200948020-0000119271781Search in Google Scholar

2Pacifici GM. Clinical pharmacokinetics of aminoglycosides in the neonate: a review. Eur J Clin Pharmacol. 2009;65:419-427. Pacifici GM Clinical pharmacokinetics of aminoglycosides in the neonate: a review Eur J Clin Pharmacol 200965419 42710.1007/s00228-008-0599-y19104791Search in Google Scholar

3Stocker M, Berger C, McDougall J, Giannoni E. Recommendations for term and late preterm infants at risk for perinatal bacterial infection. Swiss Med Wkly. 2013;143:wl3873. Stocker M Berger C McDougall J Giannoni E Recommendations for term and late preterm infants at risk for perinatal bacterial infection Swiss Med Wkly 2013143wl387310.4414/smw.2013.1387324089151Search in Google Scholar

4Szczapa J. Neonatologia. II ed.. Wydawnictwo Lekarskie PZWL, Warszawa, 2015;1-25; 79-87; 295-304. Szczapa J Neonatologia. II ed.. Wydawnictwo Lekarskie PZWL Warszawa 20151–25 79-87; 295-304Search in Google Scholar

5Królak-Olejnik B. Neonatologia: podręcznik dla studentów Wydziału Lekarskiego Uniwersytetu Medycznego oraz lekarzy specjalizujących się w neonatologii, pediatrii, medycynie rodzinnej. Uniwersytet Medyczny im. Piastów Śląskich, Wrocław, 2016;18-19; 50-62; 79-84. Królak-Olejnik B. Neonatologia: podręcznik dla studentów Wydziału Lekarskiego Uniwersytetu Medycznego oraz lekarzy specjalizujących się w neonatologii, pediatrii, medycynie rodzinnej. Uniwersytet Medyczny im. Piastów Śląskich Wrocław 201618–19 50-62; 79-84Search in Google Scholar

6Fonzo-Christe C, Guignard B, Zaugg C, Coehlo A, Posfay-Barbe KM, Gervaix A, Desmeules J, Rollason V, Combescure C, Corbelli R, Rimensberger P, Pfister R, Bonnabry P. Impact of clinical decision support guidelines on therapeutic drug monitoring of gentamicin in newborns. Ther Drug Monit. 2014;36:656-662. Fonzo-Christe C Guignard B Zaugg C Coehlo A Posfay-Barbe KM Gervaix A Desmeules J Rollason V Combescure C Corbelli R Rimensberger P Pfister R Bonnabry P. Impact of clinical decision support guidelines on therapeutic drug monitoring of gentamicin in newborns Ther Drug Monit 201436656 66210.1097/FTD.000000000000007124690586Search in Google Scholar

7Perrone V, Cattaneo D, Radice S, Sangiorgi D, Federici AB, Gismondo RM, Medaglia M, Micheli V, Vimercati S, Pallone E, Esposti LD, Clementi E. Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients. Clinicoecon Outcomes Res. 2014;6:341-348. Perrone V Cattaneo D Radice S Sangiorgi D Federici AB Gismondo RM Medaglia M Micheli V Vimercati S Pallone E Esposti LD Clementi E Impact of therapeutic drug monitoring of antiretroviral drugs in routine clinical management of patients infected with human immunodeficiency virus and related health care costs: a real-life study in a large cohort of patients Clinicoecon Outcomes Res 20146341 34810.2147/CEOR.S58036410523025053888Search in Google Scholar

8Streetman DS, Nafziger AN, Destache CJ, Bertino JS. Individualized pharmacokinetic monitoring results in less aminoglycoside-associated nephrotoxicity and fewer associated costs. Pharmacotherapy 2001;21:443-451. Streetman DS Nafziger AN Destache CJ Bertino JS Individualized pharmacokinetic monitoring results in less aminoglycoside-associated nephrotoxicity and fewer associated costs Pharmacotherapy 200121443 45110.1592/phco.21.5.443.3449011310518Search in Google Scholar

9van Lent-Evers NA, Mathôt RA, Geus WP, van Hout BA, Vinks AA. Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis. Ther Drug Monit. 1999;21:63-73. van Lent-Evers NA Mathôt RA Geus WP van Hout BA Vinks AA Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis Ther Drug Monit 19992163 7310.1097/00007691-199902000-0001010051056Search in Google Scholar

10Szymura-Oleksiak J, Cios A, Gonciarz A. Terapia monitorowana stężeniem leku we krwi u dzieci. Pediatr Dypl. 2013;17(1):64-70. Szymura-Oleksiak J Cios A Gonciarz A Terapia monitorowana stężeniem leku we krwi u dzieci Pediatr Dypl 201317164 70Search in Google Scholar

11McLawhon RW. Chapter 10 Guidelines for the Monitoring of Vancomycin, Aminoglycosides and Certain Antibiotics. IN: Therapeutic Drug Monitoring: Newer Drugs and Biomarkers. Editor: Das gupta A. 1st Edition, Cop. Elsevier, Imprint Academic Press, 2012;197-218. Hardcover ISBN: 978-0-12-385467-4. Doi: 10.1016/C2010-0-66930-6; Chapter 10 Doi: 10.1016/B978-0-12-385467-4.00010-5 McLawhon RW. Chapter 10 Guidelines for the Monitoring of Vancomycin, Aminoglycosides and Certain Antibiotics. IN: Therapeutic Drug Monitoring: Newer Drugs and Biomarkers. Editor: Das gupta A. 1st Edition, Cop Elsevier, Imprint Academic Press 2012197–218 Hardcover ISBN: 978-0-12-385467-4 10.1016/C2010-0-66930-6;Chapter10 10.1016/B978-0-12-385467-4.00010-5Open DOISearch in Google Scholar

12Fuchs A, Guidi M, Giannoni E, Werner D, Buclin T, Widmer N, Csajka C. Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates. Br J Clin Pharmacol. 2014;78(5):1090-1101. Doi: 10.1111/bcp.12444 Fuchs A Guidi M Giannoni E Werner D Buclin T Widmer N Csajka C Population pharmacokinetic study of gentamicin in a large cohort of premature and term neonates Br J Clin Pharmacol 20147851090 1101 10.1111/bcp.12444Open DOISearch in Google Scholar

13Hansen A, Forbes P, Arnold A, O’Rourke E. Once-daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels. J Perinatol. 2003;23(8):635-639. Doi: 10.1038/sj.jp.7210996 Hansen A Forbes P Arnold A O’Rourke E. Once-daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels J Perinatol 2003238635 639 10.1038/sj.jp.7210996Open DOISearch in Google Scholar

14König K, Lim A, Miller A, Saker S, Guy KJ, Barfield CP. Gentamicin trough levels using a simplifies extended-interval dosing regimen in preterm and term neworns. Eur J Pediatr. 2015;174(5):669-673. Doi: 10.1007/s00431-014-2450-z König K Lim A Miller A Saker S Guy KJ Barfield CP. Gentamicin trough levels using a simplifies extended-interval dosing regimen in preterm and term neworns Eur J Pediatr 20151745669 673 10.1007/s00431-014-2450-z25388408Open DOISearch in Google Scholar

15Valitalo PAJ, van den Anker JN, Allegaert K, de Cock RFW, de Hoog M, Simons SHP, Mouton JW, Knibbe CAJ. Novel model-based dosing guidelines for gentamicin and tobramycin in preterm and term neonates. J Antimicrob Chemother. 2015;70(7):2074-2077. Doi: 10.1093/jac/dkv052 Valitalo PAJ van den Anker JN Allegaert K de Cock RFW de Hoog M Simons SHP Mouton JW Knibbe CAJ. Novel model-based dosing guidelines for gentamicin and tobramycin in preterm and term neonates J Antimicrob Chemother 20157072074 2077 10.1093/jac/dkv052447232525766737Open DOISearch in Google Scholar

16Begg EJ, Barclay ML, Duffull SB. A suggested approach to once-daily aminoglycoside dosing. Br J Clin Pharmacol. 1995;39(6):605-609. Doi: 10.1111/j.1365-2125.1995. tb05719.x Begg EJ Barclay ML Duffull SB A suggested approach to once-daily aminoglycoside dosing Br J Clin Pharmacol 1995396605 609 10.1111/j.1365-2125.1995.tb05719.xOpen DOISearch in Google Scholar

17Micromedex Neofax Online. neofax.micromedexsolutions. com [Internet]. https://neofax.micromedexsolutions.com Accessed 2017 Sept 13. Micromedex Neofax Online. neofax.micromedexsolutions. com [Internet] https://neofax.micromedexsolutions.com Accessed 2017 Sept 13Search in Google Scholar

18Gentamicin Advia Centaur System – Principle of the Test. Internet: http://labmed.ucsf.edu/labmanual/db/resource/Centaur_Gentamicin.pdf (accessed 15 March 2017). Gentamicin Advia Centaur System – Principle of the Test Internet http://labmed.ucsf.edu/labmanual/db/resource/Centaur_Gentamicin.pdf (accessed 15 March 2017)Search in Google Scholar

19van Maarseveen EM, Sprij A, Touw DJ. Extended-interval dosing of gentamicin aiming for a drug-free period in neonates: a prospective cohort study. Ther Drug Monit. 2016;38(3):402406. Doi: 10.1097/FTD.0000000000000283 van Maarseveen EM Sprij A Touw DJ. Extended-interval dosing of gentamicin aiming for a drug-free period in neonates: a prospective cohort study Ther Drug Monit 2016383402406 10.1097/FTD.000000000000028326836810Open DOISearch in Google Scholar

20Orzechowska-Juzwenko K. Farmakologia kliniczna. Znaczenie w praktyce medycznej. Górnicki Wydawnictwo Medyczne, Wrocław, 2012;7-35,197-207. Orzechowska-Juzwenko K Farmakologia kliniczna. Znaczenie w praktyce medycznej. Górnicki Wydawnictwo Medyczne Wrocław 20127–35197-207Search in Google Scholar

21Charakterystyka Produktu Leczniczego – Gentamicin KRKA. Charakterystyka Produktu Leczniczego – Gentamicin KRKASearch in Google Scholar

22Gentamicin – Gold Standard Drug Monograph. Internet: https://www-1clinicalkey-1com-1dinicalkey.han.bg.umed.wroc.pl/#!/content/drug_monograph/6-s2.0-275 (accessed 10 March 2017). Gentamicin – Gold Standard Drug Monograph Internet https://www-1clinicalkey-1com-1dinicalkey.han.bg.umed.wroc.pl/#!/content/drug_monograph/6-s2.0-275 (accessed 10 March 2017)Search in Google Scholar

23Leggett JE. Aminoglycosides. IN. Mandell, Douglas and Bennett’s Principles and Practise of Infectious Diseases. Edited by JE Bennett, R Dolin, MJ Blasé. 8th Edition, Cop. Elsevier, Imprint Saunders, Philadelphia, 2015; Vol. 1:310-321.e7. ISBN 978-1-4557-4801-3 Doi: 10.1016/C2012-1-00075-6 ; Chapter 25 Doi: 10.1016/B978-1-4557-4801-3.00025-4 Leggett JE Aminoglycosides. IN. Mandell, Douglas and Bennett’s Principles and Practise of Infectious Diseases Edited by JE Bennett, R Dolin, MJ Blasé. 8th Edition, Cop. Elsevier, Imprint Saunders, Philadelphia 2015 Vol. 1310 321 e7. ISBN 978-1-4557-4801-3 10.1016/C2012-1-00075-6; Chapter 25 10.1016/B978-1-4557-4801-3.00025-410.1016/B978-1-4557-4801-3.00025-4Search in Google Scholar

24Dersch-Mills D, Akierman A, Alshaikh B, Sundaram A, Yusuf K. Performance of a dosage individualization table for extended interval gentamicin in neonates beyond the first week of life. J Matern Fetal Neonatal Med. 2016;29(9):1451 - 1456. Doi: 10.3109/14767058.2015.1051021 Dersch-Mills D Akierman A Alshaikh B Sundaram A Yusuf K. Performance of a dosage individualization table for extended interval gentamicin in neonates beyond the first week of life J Matern Fetal Neonatal Med 20162991451 1456 10.3109/14767058.2015.105102126043646Open DOISearch in Google Scholar

25Testa M, Fanos V, Martinelli V, Stronati M, Mussap M, Del Zompo M. Therapeutic drug monitoring of gentamicin in neonatal intensive care unit: experience in 68 newborns. J Chemother. 2007;19 (Suppl 2):39-41. Testa M Fanos V Martinelli V Stronati M Mussap M Del Zompo M. Therapeutic drug monitoring of gentamicin in neonatal intensive care unit: experience in 68 newborns J Chemother 200719 Suppl 239 4110.1080/1120009X.2007.11782443Search in Google Scholar

26Mohamed AF, Nielsen EI, Cars O, Friberg LE. Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants. Antimicrob Agents Chemother. 2012;56(1): 179188. Doi: 10.1128/AAC.00694-11 Mohamed AF Nielsen EI Cars O Friberg LE Pharmacokinetic-pharmacodynamic model for gentamicin and its adaptive resistance with predictions of dosing schedules in newborn infants Antimicrob Agents Chemother 2012561 179188 10.1128/AAC.00694-11325605722037853Open DOISearch in Google Scholar

27Antolik TL, Cunningham KJ, Alabsi S, Reimer RA. Empirical gentamicin dosing based on serum creatinine levels in premature and term neonates. Am J Health Syst Pharm. 2017;74(7):466-472. Doi: 10.2146/ajhpl60061 Antolik TL Cunningham KJ Alabsi S Reimer RA Empirical gentamicin dosing based on serum creatinine levels in premature and term neonates Am J Health Syst Pharm 2017747466 472 10.2146/ajhpl60061Open DOISearch in Google Scholar